Evolent Health’s IPO

Cravath represented Evolent Health, Inc., a market leader and pioneer in the new era of healthcare delivery and payment, in connection with its US$225 million registered initial public offering of Class A common stock. Evolent Health was founded by the University of Pittsburgh Medical Center and The Advisory Board Company and is partially owned by private equity sponsor TPG Capital, L.P. In connection with the offering, Evolent Health completed a reorganization to implement an UP‑C structure. The shares were listed on the New York Stock Exchange. The transaction closed on June 10, 2015.

The Cravath team included partner William V. Fogg and associates Michael S. Darby, Arthur L. Lotz, David J. Kohtz and Matthew L. Ploszek on corporate matters; partners Andrew W. Needham and Christopher K. Fargo and associates Antje Hagena and Andrew T. Davis on tax matters; and partner Eric W. Hilfers and associate Daniel P. Herrmann on executive compensation and benefits matters. Summer associate Eliza S. Marshall also worked on corporate matters.